Corvus Pharmaceuticals In... (CRVS)
3.21
-0.17 (-5.03%)
At close: Mar 31, 2025, 11:36 AM
Corvus Pharmaceuticals Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | 151K | 367K | 460K | 632K | 743K | 847K | 842K | 594K | 148K | n/a |
| Gross Profit | n/a | -151K | -367K | -460K | -632K | -743K | -847K | -842K | -594K | -148K | n/a |
| Operating Income | -27.55M | -23.41M | -32.56M | -38.63M | -43.76M | -48.85M | -49.22M | -56.52M | -36.98M | -13.77M | -175.64K |
| Interest Income | n/a | n/a | 654.00 | n/a | 540K | 2.18M | 2.28M | 861K | 601K | 35K | n/a |
| Pretax Income | -62.29M | -27.03M | -41.31M | -43.24M | -6M | -46.67M | -46.94M | -55.66M | -36.38M | -31.34M | -175.64K |
| Net Income | -62.29M | -27.03M | -50.05M | -38.2M | -4.82M | -43.75M | -46.94M | -55.66M | -36.38M | -31.34M | -175.64K |
| Selling & General & Admin | 8.16M | 6.73M | 8.1M | 9.52M | 11.93M | 10.88M | 10.64M | 10.22M | 7.62M | 2.42M | 134.18K |
| Research & Development | 19.39M | 16.53M | 24.47M | 29.11M | 31.83M | 37.98M | 38.59M | 46.3M | 29.36M | 11.35M | 41.45K |
| Other Expenses | n/a | n/a | 587K | 235K | 37.46M | n/a | n/a | n/a | n/a | -17.6M | n/a |
| Operating Expenses | 27.55M | 23.26M | 32.56M | 38.63M | 43.76M | 48.85M | 49.22M | 56.52M | 36.98M | 13.77M | 175.64K |
| Interest Expense | 1.82M | 1.58M | 654K | 15K | 540K | 2.18M | 2.28M | n/a | 601K | n/a | n/a |
| Selling & Marketing Expenses | n/a | -151K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | n/a | 23.41M | 32.56M | 38.63M | 43.76M | 48.85M | 49.22M | 56.52M | 36.98M | 13.77M | 175.64K |
| Income Tax | n/a | n/a | 8.74M | -5.04M | -1.17M | -2.92M | 2.28M | -842K | -594K | -35K | n/a |
| Shares Outstanding (Basic) | 60.99M | 48.03M | 46.55M | 41.85M | 29.48M | 29.35M | 27.51M | 20.49M | 15.42M | 20.41M | 170K |
| Shares Outstanding (Diluted) | 60.99M | 48.03M | 46.55M | 41.85M | 29.48M | 29.35M | 27.51M | 20.49M | 15.42M | 20.41M | 170.28K |
| EPS (Basic) | -1.02 | -0.56 | -1.08 | -0.91 | -0.16 | -1.49 | -1.71 | -2.72 | -2.36 | -1.54 | -1.03 |
| EPS (Diluted) | -1.02 | -0.56 | -1.08 | -0.91 | -0.16 | -1.49 | -1.71 | -2.72 | -2.36 | -1.54 | -1.03 |
| EBITDA | -27.55M | -26.88M | -40.94M | -42.78M | -5.36M | -48.85M | -46.09M | -54.82M | -35.78M | -31.19M | 14.64K |
| Depreciation & Amortization | n/a | 151K | 367K | 460K | 632K | 743K | 847K | 842K | 594K | 148K | 175.64K |